The increased interleukin-13 in patients with systemic lupus erythematosus: Relations to other Th1-, Th2-related cytokines and clinical findings

The levels of interleukin-13 (IL-13) in patients with systemic lupus erythe matosus (SLE) were examined and related to other Th1-/Th2- related cytokine s, clinical manifestations and other markers. Serum levels of IL-13 and oth er cytokines, soluble markers were measured by enzyme-linked immunosorbent assay (ELISA). Patients with active SLE had a significantly increased level of IL-13. Most patients with high levels of IL-13 had higher levels of IL- 6, and some patients had high levels of gamma IFN. These patients were divi ded into two groups according to the patterns of these increased cytokines; one with a high level of only Th2 related cytokines (IL-13 or IL-6) and an other with high levels of both Th2 related and Th1 related cytokines (gamma IFN or IL-2). The latter patients had high levels of soluble CD8 and CD23, and some of them had hemolytic anemia or pulmonary involvement, while most of the former patients had nephropathy. Thus, in SLE, the levels of IL-13 were increased, and the heterogeneity of increased Th2- and Th1-related cyt okines was related to that of activation markers and clinical manifestation s.